These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7980590)

  • 1. Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates.
    Bree AG; Schlerman FJ; Kaviani MD; Hastings RC; Hitz SL; Goldman SJ
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1150-7. PubMed ID: 7980590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates.
    Schlerman FJ; Bree AG; Kaviani MD; Nagle SL; Donnelly LH; Mason LE; Schaub RG; Grupp SA; Goldman SJ
    Stem Cells; 1996 Sep; 14(5):517-32. PubMed ID: 8888493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of recombinant human interleukin-6 on blood and immune parameters in middle-aged and old rhesus monkeys.
    Sun WH; Binkley N; Bidwell DW; Ershler WB
    Lymphokine Cytokine Res; 1993 Dec; 12(6):449-55. PubMed ID: 8123761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated administrations of interleukin (IL)-12 are associated with persistently elevated plasma levels of IL-10 and declining IFN-gamma, tumor necrosis factor-alpha, IL-6, and IL-8 responses.
    Portielje JE; Lamers CH; Kruit WH; Sparreboom A; Bolhuis RL; Stoter G; Huber C; Gratama JW
    Clin Cancer Res; 2003 Jan; 9(1):76-83. PubMed ID: 12538454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration.
    de Serres M; Yeager RL; Dillberger JE; Lalonde G; Gardner GH; Rubens CA; Simkins AH; Sailstad JM; McNulty MJ; Woolley JL
    Stem Cells; 1999; 17(6):316-26. PubMed ID: 10606160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
    Robertson MJ; Cameron C; Atkins MB; Gordon MS; Lotze MT; Sherman ML; Ritz J
    Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo modulation of the circulating lymphocyte subsets and monocytes by androgen.
    Yao G; Liang J; Han X; Hou Y
    Int Immunopharmacol; 2003 Dec; 3(13-14):1853-60. PubMed ID: 14636834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
    Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
    Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and pharmacodynamics of GW395058, a peptide agonist of the thrombopoietin receptor, in the dog, a large-animal model of chemotherapy-induced thrombocytopenia.
    Case BC; Hauck ML; Yeager RL; Simkins AH; de Serres M; Schmith VD; Dillberger JE; Page RL
    Stem Cells; 2000; 18(5):360-5. PubMed ID: 11007920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
    Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
    Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematological effects of pulse steroid therapy.
    Demir G; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1994; 14(3):101-6. PubMed ID: 7883386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates.
    Shinkura H; Imazeki I; Yamazaki M; Oda Y; Kotoh M; Mihara M
    Anticancer Res; 1998; 18(2A):1217-21. PubMed ID: 9615791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral but not central leptin treatment increases numbers of circulating NK cells, granulocytes and specific monocyte subpopulations in non-endotoxaemic lean and obese LEW-rats.
    Haas P; Straub RH; Bedoui S; Nave H
    Regul Pept; 2008 Nov; 151(1-3):26-34. PubMed ID: 18556075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacology of recombinant human interleukin-18 in non-human primates.
    Herzyk DJ; Soos JM; Maier CC; Gore ER; Narayanan PK; Nadwodny KL; Liu S; Jonak ZL; Bugelski PJ
    Cytokine; 2002 Oct; 20(1):38-48. PubMed ID: 12441145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.